Blood pressure lowering efficacy of alpha blockers for primary hypertension

By Shi Chunhu  

International Journal of Evidence-based Healthcare, Vol. 11, Iss. 3, 2013-09 ,pp. : 204-205

Blackwell Publishing

Access to resources Recommend Favorite

Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study

By Shimizu M.   Ogawa K.   Sasaki H.   Uehara Y.   Otsuka Y.   Okumura H.   Kusaka M.   Hasuda T.   Yamada T.   Mochizuki S.  

Current Therapeutic Research, Vol. 64, Iss. 9, 2003-11 ,pp. : 707-714

Elsevier

Access to resources Recommend Favorite

Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study

By Hsieh M.-H.   Chan P.   Sue Y.-M.   Liu J.-C.   Liang T.H.   Huang T.-Y.   Tomlinson B.   Chow M.S.S.   Kao P.-F.   Chen Y.-J.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2797-2808

Elsevier

Access to resources Recommend Favorite

Fixed-Dose Combination Therapy for Psoriasis

By Lyn C. Guenther  

American Journal of Clinical Dermatology, Vol. 5, Iss. 2, 2004-01 ,pp. : 71-77

Adis International

Access to resources Recommend Favorite

A retrospective meta-analysis of the efficacy and tolerability of fenofibrate 300 mg/d on high-density lipoprotein cholesterol levels in randomized, double-blind, comparative studies conducted in Japan

By Nakaya N.   Goto Y.  

Current Therapeutic Research, Vol. 64, Iss. 8, 2003-09 ,pp. : 634-644

Elsevier

Access to resources Recommend Favorite